Selective imidazoline receptor agonists for metabolic syndrome.
Krentz
A J
AJ
Department of Diabetes and Endocrinology, Southampton General Hospital, UK.
Evans
A J
AJ
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D007093:Imidazoles / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D054755:Imidazoline Receptors; D007333:Insulin Resistance; D011955:Receptors, Drug / Q000819:agonists*; D013564:Sympathetic Nervous System / Q000503:physiopathology; D013577:Syndrome
D000959:Antihypertensive Agents; D007093:Imidazoles; D054755:Imidazoline Receptors; D011955:Receptors, Drug; C043482:moxonidine